Multiple Sclerosis Drugs Could Transform Market Again

By | September 26, 2014

Scalper1 News

Over the last four years, life for multiple-sclerosis patients has changed for the better as a new generation of powerful oral drugs has moved into a market dominated by injectables. But things aren’t done changing yet, as a September conference in Boston showed. At the meeting, held jointly by the American and European Committees for Treatment and Research in MS, the star presentation came from small biotech Receptos (RCPT). The phase-two Scalper1 News

Scalper1 News